Solazyme (SZYM) Tops Q4 EPS by 2c

Solazyme (NASDAQ: SZYM) reported Q4 EPS of ($0.45), $0.02 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $14.5 million versus the consensus estimate of $17.7 million.

For earnings history and earnings-related data on Solazyme (SZYM) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c
• KULR Technology Group (KULR) Misses Q2 EPS by 39c